Research Ethics Committees: Can They Contribute to the Improvement of Clinical Research in Europe

Journal of Ambulatory Care Management

Volumn 27, Issue 2, 2004, Pages 154-165

  Liberati, Alessandro ^a,b,c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Bioethics; Ethics committees clinical; Ethics committees research; Scientific misconduct; Therapeutic human experimentation

Indexed keywords

CLINICAL PROTOCOL; CLINICAL RESEARCH; EUROPE; INFORMED CONSENT; PUBLICATION; REPRODUCIBILITY; RESEARCH ETHICS; REVIEW;

EID: 1642326714     PISSN: 01489917     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004479-200404000-00012     Document Type: Review

References (43)

1. Alberti, K. G. M. M. (2000). Multicentre research ethics committees: Has the cure been worse than the disease? British Medical Journal, 320, 1157-1158.
2. Angell, M. (2000). Is academic medicine for sale? New England Journal of Medicine, 342(20), 1516-1518.
3. Antes, G., Chalmers, I. (2003). Under-reporting of clinical trials is unethical. Lancet, 361, 978.
4. Ashcroft, R., & Pfeffer, N. (2001). Ethics behind closed doors. Do research ethics committees need secrecy? British Medical Journal, 322, 1294-1296.
5. Assendelft, W. J. J., Koes, B. W., Knipschild, P. G., & Bouter, L. M. (1995). The relationships between methodological quality and conclusions in review of spinal manipulation. JAMA, 274, 1942-1948.
6. Blunt, J., Savulescu, J., & Watson, A. J. M. (1998). Meeting the challenges facing research ethics committees: some practical suggestions. British Medical Journal, 316, 58-61.
7. Born, G. V., & Collins, R. (1997). Aspirin vs clopidogrel: The wrong question? Lancet, 349, 806-807.
8. Campbell, E. G., Weissman, J. S., Clarridge, B., Yucel, R., Causino, N., Blumenthal, D., et al. (2003). Characteristics of medical schools faculty members serving in Institutional Review Boards (IRBs): Results of a national survey. Academic Medicine, 78(8), 831-836.
9. Cave, E., & Holm, S. (2002). New governance arrangements for research ethics committees: Is facilitating research achieved at the costs of participants interests? Journal of Medical Ethics, 28, 318-321.
10. Chalmers, I. (2001). Using systematic reviews and registers of ongoing trials for scientific and ethical trial design, monitoring, and reporting. In M. Egger, G. D. Smith, D. G. Altman (Eds.), Systematic reviews in health care: Meta analysis in context (pp. 429-443). London: BMJ Books.
11. Dal Re, R., Espada, J., & Ortega, R. (1999). Performance of research ethics committees in Spain. A prospective study of 100 applications for clinical protocols on medicines. Journal of Medical Ethics, 25, 268-273.
12. Davidoff, F., DeAngelis, C. D., & Drazen, J. M. (2001). Sponsorship, authorship and accountability. New England Journal of Medicine, 345, 825-827.
13. Decreto Ministeriale. Linee Guida di Riferimento per la Istituzione dei Comitati Etici. 2003. Gazzetta Ufficiale n. 122 del 28 maggio 1998. Retrived September 20, 2003, from http://oss-sper-clin.sanita.it/normativa/DM18& lowbar;03_1998.pdf.
14. Dickersin, K., & Rennie, D. (2003). Registering clinical trials. JAMA, 290, 516-523.
15. Emanuel, E., Wendler, D., & Grady, C. (2000). What makes clinical research ethical? JAMA, 283, 2701-2711.
16. European Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001. On the approximation of law, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal product for human use. Official Journal of the European Communities L121, 1.5.2001, (pp. 34-41).
17. Federman, D. D., Hanna, K. E., & Rodriguez, L. L. (2003). Responsible research: A system approach to protecting research patients. Washington, DC: National Academies Press. Retrieved from www.nap.edu).
18. Garattini, S., Bertelè, V., Li & Bassi, L. (2003). How can research ethics committees protect patients better? British Medical Journal, 326, 1199-1201.
19. Garattini, S., & Liberati, A. (2000). The risk of bias by omitted research. British Medical Journal, 321, 845-846.
20. Geraci, E. (1992). Unethical placebo assignment in clinical trials of thrombolysis. Journal of American College of Cardiology, 20(5), 1302-1303.
21. Huston, P., & Peterson, P. (2001). Withholding proven treatment in clinical research. New England Journal of Medicine, 345(12), 912-914.
22. Italian Cochrane Centre. (2002, October) VIII Annual meeting: The role of research ethics committees. Verona, Italy. Retrieved September 18, 2003 from http://www.cochrane.it/main.asp?pag = convegnoco-mitati&menu=arc.
23. Jenkins, V., & Fallowfield, L. (2000). Reasons for accepting or declining to participate in randomised clinical trials for cancer therapy. British Journal of Cancer, 82, 1783-1788.
24. Kravitz, D. A. (2000). Failure to publish results of epidemiologic studies is unethical. Epidemiology, 283, 2701-2711.
25. Lenfant, C. (2003). Shattuck Lecture. Clinical research to clinical practice: Lost in translation? New England Journal of Medicine, 349(9), 868-874.
26. Lurie, P., & Wolfe, S. (1997). Unethical trials of intervention to reduce perinatal transmission of the human immunodeficiency virus in developing countries. New England Journal of Medicine, 337, 853-856.
27. Mann, H. (2002). Research ethics committees and public dissemination of clinical trials results. Lancet, 360, 406-408.
28. Martini, N., Tomino, C., & Liberati, A. (2003). Role of research ethics committees in follow up and publication of results. Lancet, 361, 2246.
29. Medical Research Council. (2003). Medical Research Council response to the Medicine and Health Care Products Regulatory Agency (MHRA) consultation letter on the Medicine for Human Use (Clinical Trials) Regulations (MLX 287) and draft legislation Retrieved September 28, 2003, from http://www.mrc. ac.uk/prn/pdf.good_regulation_clinical_trials.pdf.
30. Ministero della Salute. (2003). Osservatorio Nazionale sulla Sperimentazione Clinica dei Medicinali (responsabile Carlo Tomino). Bollettino no. 2, Giugno 2003. Bollettino di Informazione sui Farmaci (BIF) (inserto Speciale) Anno X n. 3-4. Retrieved September 27, 2003, from http://oss-sper-clin.sanita.it/dati_ pubblicazioni.htm.
31. Ministero della Salute. (2003). Osservatorio Nazionale sulla Sperimentazione Clinica dei Medicinali (responsabile Carlo Tomino). Bollettino no. 2, Giugno 2003. Bollettino di Informazione sui Farmaci (BIF) (inserto Speciale) Anno X n. 3-4. Retrieved September 27, 2003, from http://oss-sper-clin.sanita.it/dati_ pubblicazioni.htm.
32. Nicolucci, A., Grilli, R., Alexanian, A. A., Apolone, G., Torri, V., & Liberati, A. (1989). Quality evolution and clinical implication of randomised controlled trials in the treatment of lung cancer. A lost opportunity for metanalysis. JAMA, 262, 2101-2107.
33. Oxman, A., Chalmers, I., & Sackett, D. L. (2001). A practical guide to informed consent to treatment. British Medical Journal, 323, 1464-1466.
34. Rossetti, L., Marchetti, I., Orzalesi, N., Scorpiglione, N., & Liberati, A. (1993, Novermber 11) Is proper methodology associated with the use of clinically relevant end point? The case of randomised control trials on medical treatment of open angle glaucoma (Document no. 100). Online Journal of Current Clinical Trials.
35. Rothman, K. J., & Michels, K. B. (1994). The continuing unethical use of placebo controls. New England Journal of Medicine, 331, 394-398.
36. Sackett, D. (2002). Clinical epidemiology: What, who and whither. Journal of Clinical Epidemiology, 55(12), 1161-1166.
37. Salit, I. E. (1992). Why was treatment of cytomegalovirus retinitis randomised? Annals of Internal Medicine, 116(7), 104-105.
38. Savulescu, J., Chalmers, I., & Blunt, J. (1996). Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability. British Medical Journal, 313, 1390-1393.
39. Sutherland, L. R., May, G. R., & Shaffer, E. A. (1993). Sulfasalazine revisited: A meta-analysis of 5 Aminosalycitic acid in the treatment of ulcerative colitis. Annals of Internal Medicine, 118, 540-549.
40. Update Software. (2003). The Cochrane Library: Evidence on the effects of health care. (Issue 3). Oxford: Author.
41. Varmus, H., & Satcher, D. (1997). Ethical complexities of conducting research in developing countries. New England Journal of Medicine, 337, 847-849.
42. Who's afraid of the European Clinical Trials Directive? [Editorial]. (2003). Lancet, 361, 2167.
43. World Medical Association Declaration of Helsinki. (2000). Ethical principles for medical research involving human subjects. Edinburgh: World Medical Association General Assembly.